FANCA-dependent FEN1 recruitment suppresses transcription-replication conflicts and PARPi sensitivity
Molecular Cell · 2026-08 · 86 (15) · 2924-2938.e10
DOI: 10.1016/j.molcel.2026.05.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026-08. Verfasst von Qinhong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department o…. Hauptthemen laut MEDLINE: DNA Replication, Transcription, Genetic, Flap Endonucleases, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Synthetic lethality (SL) underlies the success of PARP1 inhibitors (PARPi) in treating homologous recombination (HR) deficient cancers, yet their broader applicability beyond HR-deficiency remains poorly defined. Here, we performed an in vivo CRISPR screen that identifies FANCA deficiency as a driver of tumor progression and PARPi SL, validated across diverse human cancer models. Notably, FANCA loss does not impair HR but instead disrupts FEN1 recruitment to replication forks, leading to defective Okazaki fragment maturation, lagging-strand single-strand DNA gap accumulation, and RPA exhaustion upon PARPi treatment. Additionally, FANCA loss in oncogene-expressing cells promotes transcription replication conflict (TRC) accumulation selectively on the lagging strand and sensitizes HR-proficient cells to PARPi, a phenotype reversible by RNA polymerase II inhibition or RNase H overexpression. Together, these findings identify FANCA deficiency as a context-specific PARPi vulnerability and establish FANCA as a key suppressor of TRCs required for genomic stability under oncogenic replication stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lineberger Comprehensive Cancer Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Radiation Oncology, School of Medicine, The University of North Caro…
- Lineberger Comprehensive Cancer Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Lineberger Comprehensive Cancer Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Curriculum in Genetics and Molecular Biology, School of Medicine, The University o…
- Department of Genetics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- National Cancer Institute
- Breast Cancer Research Foundation
- University of North Carolina
- National Institutes of Health
- V Foundation for Cancer Research
Zitieren
APA
Wang, Q., Ellington, S. W., Guerra, P., Gharibpoor, F., Simpson, D. A., Cho, M. G., Beltran, A., & Gupta, G. P. (2026). FANCA-dependent FEN1 recruitment suppresses transcription-replication conflicts and PARPi sensitivity. Molecular Cell, 86(15), 2924-2938.e10. https://doi.org/10.1016/j.molcel.2026.05.027
Vancouver
Wang Q, Ellington SW, Guerra P, Gharibpoor F, Simpson DA, Cho MG, et al. FANCA-dependent FEN1 recruitment suppresses transcription-replication conflicts and PARPi sensitivity. Molecular Cell. 2026;86(15):2924-2938.e10. doi:10.1016/j.molcel.2026.05.027
BibTeX
@article{Wang2026,
author = {Wang, Qinhong and Ellington, Simon W and Guerra, Paolo and Gharibpoor, Faeze and Simpson, Dennis A and Cho, Min-Guk and Beltran, Adriana and Gupta, Gaorav P},
title = {FANCA-dependent FEN1 recruitment suppresses transcription-replication conflicts and PARPi sensitivity},
journal = {Molecular Cell},
year = {2026},
volume = {86},
number = {15},
pages = {2924--2938.e10},
doi = {10.1016/j.molcel.2026.05.027}
}
EUVIMED